^
Association details:
Biomarker:No biomarker
Cancer:Vulvar Cancer
Drug:capecitabine (Thymidylate synthase inhibitor) +
mitomycin (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
09/22/2023
Excerpt:
Vulvar Cancer: SYSTEMIC THERAPY…Other Recommended Regimens…Capecitabine/mitomycin…